Literature DB >> 6713447

Distribution of cardiac output, oxygen consumption and lactate production in canine endotoxin shock.

A A van Lambalgen, W Bronsveld, G C van den Bos, L G Thijs.   

Abstract

Endotoxin causes shock accompanied by compensatory changes such as redistribution of cardiac output and increased oxygen extraction. We studied these effects in anaesthetised dogs (etomidate: 4 mg X kg-1 X h-1, n = 14) randomly assigned to a control (n = 6) and a shock group (endotoxin 1.5 mg X kg-1; n = 8). We measured left ventricular pressure, LVEDP and LVdP/dt (Millar microtip), mean systemic, central venous and pulmonary artery pressure (Statham P23Db), cardiac output (thermodilution), organ flow (microspheres, 15 micron, 5 labels), bloodgases (PO2, PCO2), pH and lactate. All measurements were performed before and at 60, 90, 120 and 150 min after endotoxin or saline. Sixty minutes after endotoxin mean systemic pressure, LVdP/dt and cardiac output had decreased (by 60, 50 and 35%), while heart rate had increased (by 30%). Arterial PO2 was lower after endotoxin (-29%), haematocrit and mixed venous PCO2 were higher (+16 and +38%) and arterial pH had decreased from 7.34 to 7.14. After endotoxin perfusion of heart and adrenals did not change but muscle perfusion increased (by 33% at t = 90). Endotoxin caused vasoconstriction in spleen and kidneys: the percentage of cardiac output to these organs thus decreased (by 50 and 69%). Sixty minutes after endotoxin we found vasodilatation in the hepatic arterial, pancreatic, and gastrointestinal beds. Later the percentage of cardiac output to these beds decreased. Systemic arterio-venous shunting fell (from 6.5 to 0.7%). Systemic and splanchnic oxygen extraction increased (by 66 and 71% at t = 60): oxygen consumption hardly changed; 60 min after endotoxin it tended to decrease. During shock serum lactate rose (by 167% at t = 60) before oxygen consumption fell. Myocardial oxygen consumption did not alter during shock but the tension time index decreased.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713447     DOI: 10.1093/cvr/18.4.195

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Regional changes in cerebral blood flow during acute endotoxemia.

Authors:  Z Yang; U Kreimeir; K Messmer
Journal:  J Tongji Med Univ       Date:  1987

3.  An Ovine Model of Hyperdynamic Endotoxemia and Vital Organ Metabolism.

Authors:  Liam Byrne; Nchafatso G Obonyo; Sara Diab; Kimble Dunster; Margaret Passmore; Ai Ching Boon; Louise See Hoe; Karen Hay; Frank Van Haren; John-Paul Tung; Louise Cullen; Kiran Shekar; Kathryn Maitland; John F Fraser
Journal:  Shock       Date:  2018-01       Impact factor: 3.454

4.  Pathology influences blood pressure change following vagal stimulation in an animal intubation model.

Authors:  Peter Jones; Laurent Guillaud; Christophe Desbois; Jean-Francois Benoist; Helene Combrisson; Stephane Dauger; Mark J Peters
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

5.  Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis.

Authors:  Lui G Forni; William McKinnon; Gwyn A Lord; David F Treacher; Jean-Marie R Peron; Philip J Hilton
Journal:  Crit Care       Date:  2005-09-13       Impact factor: 9.097

6.  Preservation of renal blood flow by the antioxidant EUK-134 in LPS-treated pigs.

Authors:  Sheldon Magder; Dimitrios G Parthenis; Imad Al Ghouleh
Journal:  Int J Mol Sci       Date:  2015-03-25       Impact factor: 5.923

7.  Causes of metabolic acidosis in canine hemorrhagic shock: role of unmeasured ions.

Authors:  Dirk Bruegger; Gregor I Kemming; Matthias Jacob; Franz G Meisner; Christoph J Wojtczyk; Kristian B Packert; Peter E Keipert; N Simon Faithfull; Oliver P Habler; Bernhard F Becker; Markus Rehm
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.